B
Burc Barin
Publications - 43
Citations - 2157
Burc Barin is an academic researcher. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 21, co-authored 41 publications receiving 1944 citations.
Papers
More filters
Journal ArticleDOI
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Peter G. Stock,Burc Barin,Barbara Murphy,Douglas W. Hanto,Jorge Diego,Jimmy A. Light,Charles E. L. B. Davis,Emily A. Blumberg,David Simon,Aruna Subramanian,J. Michael Millis,G. Marshall Lyon,Kenneth L. Brayman,Doug Slakey,Ron Shapiro,Joseph K. Melancon,Jeffrey M. Jacobson,Valentina Stosor,Jean L. Olson,Donald Stablein,Michelle E. Roland +20 more
TL;DR: In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection.
Journal ArticleDOI
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
Michelle E. Roland,Burc Barin,Laurie Carlson,Lynda A. Frassetto,Norah A. Terrault,R. Hirose,Chris E. Freise,Leslie Z. Benet,Nancy L. Ascher,John P. Roberts,Barbara Murphy,M. J. Keller,Kim M. Olthoff,Emily A. Blumberg,Kenneth L. Brayman,Stephen T. Bartlett,Charles E. L. B. Davis,Joseph M. McCune,Barry M. Bredt,Donald Stablein,Peter G. Stock +20 more
TL;DR: Good transplant and HIV‐related outcomes among kidney transplant recipients, and reasonable outcomes among liver recipients suggest that transplantation is an option for selected HIV‐infected patients cared for at centers with adequate expertise.
Journal ArticleDOI
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
Norah A. Terrault,Michelle E. Roland,Thomas D. Schiano,Lorna Dove,Michael T. Wong,Fred Poordad,Margaret V. Ragni,Burc Barin,David Simon,Kim M. Olthoff,Lynt B. Johnson,Valentina Stosor,Dushyantha Jayaweera,John J. Fung,Kenneth E. Sherman,Aruna Subramanian,J. Michael Millis,Douglas P. Slakey,Carl L. Berg,Laurie Carlson,Linda D. Ferrell,Donald Stablein,Jonah Odim,Lawrence Fox,Peter G. Stock +24 more
TL;DR: It is indicated that HCV per se is not a contraindication to LT in HIV patients, but recipient and donor selection and the management of acute rejection strongly influence outcomes.
Journal ArticleDOI
Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
Gaudensia Mutua,Eduard J. Sanders,Eduard J. Sanders,Peter M. Mugo,Omu Anzala,Jessica E. Haberer,David R. Bangsberg,Burc Barin,James F. Rooney,David Mark,Paramesh Chetty,Patricia E. Fast,Frances Priddy +12 more
TL;DR: Safety and adherence data from the first trial of an intermittent PrEP regimen among Kenyan men who have sex with men (MSM) and female sex workers are presented to determine whether adherence to post-coital PrEP could be comparable to more standard regimens.
Journal ArticleDOI
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity
Barry Peters,Walter Jaoko,Eftyhia Vardas,George Panayotakopoulos,Patricia E. Fast,C. Schmidt,Jill Gilmour,Mampedi Bogoshi,Gloria Omosa-Manyonyi,Len Dally,Linda S. Klavinskis,Bashir Farah,Tony Tarragona,Pierre-Alexandre Bart,Andrew Robinson,Colleen Pieterse,Wendy Stevens,Richard Thomas,Burc Barin,Andrew J. McMichael,James McIntyre,Giuseppe Pantaleo,Tomáš Hanke,Job J. Bwayo +23 more
TL;DR: This HIV-1 vaccine candidate was in general safe and well-tolerated; local reactions were common, but tolerable; Detectable immune responses were infrequent.